Kultejas News
Box Office

Drugs case: NCB rumors of giving clean chit to Deepika Padukone, Shraddha Kapoor and Sara Khan Khan

new Delhi: The Narcotics Control Bureau last week convicted Deepika Padukone, Sara Ali Khan, Shraddha Kapoor and Rakul Preet Singh in connection with the investigation into the alleged Bollywood drugs nexus. Since morning, there are speculations that NCB has given a clean chit to Deepika, Sara and Shraddha in the drug related case. Although the agency did not release any official statement, the news of the three leading women was cleared of all allegations that spread like wildfire.

According to a report in a leading daily, an NCB official has denied reports of the agency giving a clean chit to the actresses mentioned above.

“The news article mentions that the drugs law enforcement agency investigated by the NCB is devoid of facts and truth,” the NCB official told Mumbai Mirror.

During the NCB’s inquiry, three Tinsel town divisions have denied any substance abuse. During the investigation, Deepika was called by NCB after an alleged WhatsApp chat with manager Karishma Prakash. He reportedly confessed to his ‘WhatsApp drugs chat’ when he was confronted by his manager Karishma.

Sara Ali Khan, who made her Bollywood debut with ‘Kedarnath’ with Sushant Singh Rajput, said she did not take drugs. According to reports, she admitted that her relationship with SSR ended in 2019.

Shraddha, who worked with Sushant in ‘Chhichhore’, said that she was seen taking drugs between shoot breaks in her vanity van in ‘Dil Bachera’. She also admitted that a party was held at Sushant’s Pavana farmhouse after the release of ‘Chhichhore’.

We had earlier informed you that NCB will issue summons to three Bollywood A-listers after the agency has collected enough evidence in relation to the drugs related case. Three of Bollywood’s biggest giants begin with S, R and A and have worked in films with Deepika Padukone.

Source link

Related posts

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More